Publications by authors named "Steven D Green"

Claim this Profile
H
How I treat secondary acute myeloid leukemia.
Steven D Green, Eunice S Wang

Blood· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute leukemia with rearrangement: A master of disguise.
Sawyer J Bawek, Eunice S Wang, Steven D Green

Leuk Res Rep· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemtuzumab ozogamicin plus standard induction hemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia.
Hassan Awada, Mina Abdelmalek, Tara Cronin, Jeffrey Baron, Zakariya Kashour, Steven D Green

Blood Cancer J· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 or Not TP53: That Is the Question.
Steven D Green, Joshua F Zeidner

Clin Cancer Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering Tools for Regulating Hypoxia in Tumour Models.
Min Hee Kim, Steven D Green, Chien-Chi Lin, Heiko Konig

J Cell Mol Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD123-targeted therapy in acute myeloid leukemia.
Manuel Ricardo Espinoza-Gutarra, Steven D Green, Joshua F Zeidner, Heiko Konig

Expert Rev Hematol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of fever and neutropenia in the adult patient with acute myeloid leukemia.
Andrew M Peseski, Mitchell McClean, Steven D Green, Cole Beeler, Heiko Konig

Expert Rev Anti Infect Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical conundrum: managing iron overload after renal transplantation.
Binayak Upadhyay, Steven D Green, Nabin Khanal, Aśok C Antony

BMJ Case Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary AML Emerging After Therapy with Hypomethylating Agents: Outcomes, Prognostic Factors, and Treatment Options.
Daniel R Richardson, Steven D Green, Matthew C Foster, Joshua F Zeidner

Curr Hematol Malig Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Acute Myeloid Leukemia in the Era of Genomics-Achievements and Persisting Challenges.
Steven D Green, Heiko Konig

Front Genet· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis